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Abstract
Background: Hepatitis D virus (HDV) infection is considered to cause more severe hepatitis than hepatitis B virus
(HBV) monoinfection. With more than 9.5 million HBV-infected people, Vietnam will face an enormous health burden.
The prevalence of HDV in Vietnamese HBsAg-positive patients is speculative. Therefore, we assessed the
prevalence of HDV in Vietnamese patients, determined the HDV-genotype distribution and compared the findings
with the clinical outcome.
Methods: 266 sera of well-characterized HBsAg-positive patients in Northern Vietnam were analysed for the
presence of HDV using newly developed HDV-specific RT-PCRs. Sequencing and phylogenetic analysis were
performed for HDV-genotyping.
Results: The HDV-genome prevalence observed in the Vietnamese HBsAg-positive patients was high with 15.4%
while patients with acute hepatitis showed 43.3%. Phylogenetic analysis demonstrated a predominance of HDV-
genotype 1 clustering in an Asian clade while HDV-genotype 2 could be also detected. The serum aminotransferase
levels (AST, ALT) as well as total and direct bilirubin were significantly elevated in HDV-positive individuals (p<0.05).
HDV loads were mainly low (<300 to 4.108 HDV-copies/ml). Of note, higher HDV loads were mainly found in HBV-
genotype mix samples in contrast to single HBV-infections. In HBV/HDV-coinfections, HBV loads were significantly
higher in HBV-genotype C in comparison to HBV-genotype A samples (p<0.05).
Conclusion: HDV prevalence is high in Vietnamese individuals, especially in patients with acute hepatitis B. HDV
replication activity showed a HBV-genotype dependency and could be associated with elevated liver parameters.
Besides serological assays molecular tests are recommended for diagnosis of HDV. Finally, the high prevalence of
HBV and HDV prompts the urgent need for HBV-vaccination coverage.
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Introduction
Hepatitis D virus (HDV) infection is considered to account for
more severe complications of viral hepatitis with rapid
progression to cirrhosis, increased risk of hepatic
decompensation and death compared to hepatitis B virus
(HBV) monoinfection [1,2]. Hepatitis D can occur only in HBV
surface antigen (HBsAg) positive individuals as HDV is a
defective RNA virus, comparable to satellite viruses and
viroids, that requires HBsAg for its propagation [3,4]. The
occurrence of Hepatitis D is the result of either a super-
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infection of chronic hepatitis B (CHB) infection or a
simultaneous acute HBV and HDV co-infection.
The hepatitis D virion, a spherical hybrid particle of
approximately 36 nm in diameter, is composed of an outer coat
containing HBsAg and host lipids. The inner nucleocapsid
consists of small and large hepatitis D delta antigen (HDAg)
molecules and a single-stranded, circular RNA-genome of
approximately 1.7 kb [4-6]. The unique open reading frame of
the HDV genome encodes the HDAg which is transcribed as a
small HDAg (sHDAg) and a large HDAg (LHDAg) [4]. The
sHDAg is required for HDV genome synthesis while the LHDAg
inhibits HDV RNA synthesis and is essential for HDV particle
formation [7].
Earlier studies have demonstrated the existence of eight
HDV-genotypes with nucleotide sequence diversity of up to
16% within the same HDV-genotype compared to 20-36%
diversity between different HDV-genotypes [8,9]. HDV-
genotype 1 is distributed worldwide and represents the
dominant genotype in Europe [10]. HDV-genotype 2 is mainly
detectable in the Far East [11-13], and HDV-genotype 3 is
observed exclusively in the northern part of South America
[14]. HDV-genotypes 4 is detected in Taiwan [15] and Japan
[16,17], HDV-genotype 5 to 8 have their source in Africa [8].
HDV-genotype 1 can be associated with both severe and mild
diseases, whereas HDV-genotype 2 induces mainly a mild
disease course [18]. HDV-genotype 3 was linked to severe
outbreaks of hepatitis [19] and variants of HDV-genotype 4
were either associated with mild or severe liver diseases [20].
Current treatment options of chronic hepatitis D include
interferon (PEG-IFN-alpha) and nucleoside/nucleotide
analogues [21-23]. However, increasing studies reveal an
ineffectiveness of these nucleoside/nucleotide analogues and
the poor response rate to interferons [24,25].
Consecutive multicenter studies have shown a decrease in
HDV prevalence in former highly endemic countries, such as
Italy, where the prevalence of HDV declined from 23% in 1983
to 8.3% in 1997 [26]. A reduction of HDV prevalence was also
observed in Taiwan (23.7% to 4.2%) [27], Spain (15.1% to
7.1%) [28], and Turkey (29% to 12.1%) over time [10].
Due to the late introduction of a HBV vaccination program in
2003, more than 9.5 million people are estimated to be
chronically infected with HBV with 10.7% of the general
population being HBsAg-positive [29,30], while HBV-related
mortality may increase to 40.000 individuals in 2025 [31]. HBV
infection is therefore a major public health burden in Vietnam.
A previous study reported of a very low HDV seroprevalence
among Vietnamese HBsAg-positive individuals from rural
districts in Northern Vietnam (1.3%) [32]. Moreover, another
study reported of 0% (0/73) HDV RT-PCR-positive individuals
in Ho Chi Minh City, in Southern Vietnam [33]. However, these
findings are in sharp contrast to reports from other regional
countries in South-East Asia. In Malaysia a seroprevalence of
4.9% was observed whereas 20-34% HDV sero-positive
individuals were found among intravenous drug users in Kuala
Lumpur [34]. In Thailand, the HDV seroprevalence and PCR-
positivity was up to 21.8% [35]. Although Malaysia and
Thailand have implemented hepatitis B immunization programs
for infants already in the late 1980s and early 1990s,
respectively, HDV infection is unexpectedly appeared to be
less common in Vietnam compared to these countries.
In this study utilizing a well-characterized Vietnamese HBV
patient cohort positive for HBsAg, we detected the prevalence
of HDV, determined the circulating HDV-genotypes, and




Two hundred sixty-six Vietnamese HBsAg-positive patients
were included in this study. All patients were enrolled at Tran
Hung Dao Hospital, Bach Mai hospital and 103 Military Hospital
in Hanoi, Vietnam between 2000 and 2009. All patients showed
negative serology for hepatitis C virus (HCV) and human
immunodeficiency virus (HIV). None of them had a history of
alcohol or drug abuse. Of these, there were 30 acute hepatitis
B (AHB) patients, 62 chronic hepatitis B (CHB) patients, 84
liver cirrhosis (LC) patients and 90 hepatocellular carcinoma
(HCC) patients. The patients have been well-characterized
including clinical and subclinical profiles, such as liver
aminotransferases, total bilirubin and direct bilirubin in previous
studies [36,37].
Detection of HDV RNA Genomes
Nucleic acid was extracted from patient sera using High Pure
Viral Nucleic Acid Kit (Roche, Grenzach-Wyhlen, Germany)
according to the manufacturer´s instruction and stored until use
in aliquots at -80°C. We employed HDV specific nested/semi-
nested as well as real time PCR approaches for HDV detection
and quantification. The first round of HDV-specific nested RT-
PCR was performed using a one-step RT-PCR kit (QIAgen,
Hilden, Germany) and a primer pair of HDV-04 and HDV-05
(Table 1). Two primers, HDV-06 and HDV-07, were used as
the nested primers for the second PCR (Table 1). Primer
design and localization in the HDV genome are shown in
Figure 1. The cDNA synthesis and pre-denaturation was
performed at 50°C for 30 minutes and followed by 95°C for 15
minutes. The PCR amplification was for 35 cycles including:
denaturing at 94°C for 30 seconds, annealing at 56°C for 30
seconds, extending at 72°C for 45 seconds and followed by a
final extension for 10 min at 72°C. The nested PCR was
initiated by a denaturation step at 95°C for 2 min and 29 cycles
at 94°C for 30 seconds, 58°C for 30 seconds, 72°C for 45
seconds and followed by a final extension for 5 min at 72°C.
Five µl of each reaction was analysed using 1.5% agarose
gelelectrophoresis.
To exclude contamination during sample processing, we
integrated a new semi-nested HDV-specific RT-PCR to amplify
a different region of the HDV genome using the sense primer
HDV-19 and antisense primers HDV-22 and HDV-20 (Figure 1
and Table 1) for the first and second PCR round, respectively.
Primer design and localization in the HDV genome are shown
in Figure 1. Semi-nested RT-PCR run was performed
according the HDV nRT-PCR program as described above.
Resulting RT-PCR amplicons were sequenced to determine
patient-specific HDV isolates.
HDV Prevalence in Northern Vietnam
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HDV-specific quantitative real time RT-PCR (qPCR) was
performed as described recently [38]. In brief, 10µl extracted
RNA was used for one-step quantitative RT-PCR with two
forward primers (forward primer 1: 5´-
TGGACGTKCGTCCTCCT-3´and forward primer 2: 5´-
TGGACGTCTGTCCTCCTT-3´), a reverse primer (5´-
TCTTCGG-GTCGGCATGG-3´) and probe [5´-(5/6-
carboxyfluorescein-ATGCCCAGGTCGGAC-5/6-
carboxytetramethylrhodamine)-3]. A serial dilution of pSVL-
HDV plasmids with concentrations from 3.04 log10 copies/µl to
5.04 log10 copies/µl was used as standard and to calibrate the
system as described [38]. The processed data was analyzed
by the Lightcycler instrument data analysis software (Roche
Diagnosis). The lower detection limit of the HDV-specific
quantitative RT-PCR was 15 copies/ml and the linearity was
300 to 107 copies/ml [38]. Sample processing (DNA/RNA-
extraction, template preparation, master-mix preparation) and
PCR were done in separate laboratory rooms, which are all
certified for molecular diagnostics using standard precautions
to prevent assay contamination.
Sequencing and Phylogenetic Analysis
For sequencing, the RT-PCR products were purified by Exo
SAP-IT kit (USB Corporation, Ohio, USA) according to the
manufacturer´s instruction. Sequencing reactions were
performed using 1-5µl purified PCR products, 1µl BigDye
reaction mix (Life Technologies, Applied Biosystems,
Darmstadt, Germany) and 0.5µM of the primers HDV-06,
HDV-07, HDV-19 and HDV-20. Sequencing results were
analyzed using BioEdit 9.7 software (http://
www.mbio.ncsu.edu/BioEdit/bioedit.html) and Geneious Pro
(Version 5.5.7, Biomatters Ltd, Auckland, New Zealand, http://
www.geneious.com). The phylogenetic tree reconstruction and
the mean value of genetic diversity of DNA sequences were
carried out by MEGA 5 software [39]. The evolutionary history
was inferred using the Neighbor-Joining method. The
evolutionary distances were computed using the Maximum
Composite Likelihood method. For alignment and HDV-
genotyping, eight prototype HDV-genotype sequences
retrieved from the NCBI Gene bank were used (HDV-genotype
1: X77627, M92448, AB118848, AJ000558, X85253,
AY633627, AF098261; HDV-genotype 2: AJ309880, X60193,




HDV-04 GGATGCCCAGGTCGGACCG 856-874 1st PCR
HDV-05 AAGAAGAGRAGCCGGCCCGY 1159-1179 1st PCR
HDV-06 ATGCCATGCCGACCCGAAGA 888-907 2nd PCR
HDV-07 GGGGAGCGCCCGGDGGCGG 1104-1122 2nd PCR
HDV-19 GGACCCCTTCAGCGAACAG 316-334 1st&2nd PCR
HDV-20 GGCCATCAGGTAAGAAAGGA 672-691 1st PCR
HDV-22 CACTCGGATGGCTAAGGGAG 819-838 2nd PCR
Numbering is according to HDV strain NC1001653
doi: 10.1371/journal.pone.0078094.t001
U19598, AF104624; HDV-genotype 3: AB037948; HDV-
genotype 4: AF209859; HDV-genotype 5: AM183326; HDV-
genotype 6: AM183329; HDV-genotype 7: AM183333; HDV-
genotype 8: AX741169).
Statistical Analysis
Statistical analysis was performed by using SPSS release 20
(IBM Corporation, Armonk, NY, USA) and Prism5 software
(version 5.01, GraphPad Software, San Diego California USA,
www.graphpad.com). Categorical data were compared by
Fisher´s exact test. Non-parametric data were compared by
using the Mann-Whitney U test, with a 2-tailed p-value <0.05
considered to be statistically significant.
Ethics Statement
The study was approved by the Institutional Review Board of
Hanoi University of Medicine, Hanoi, Vietnam and the
Institutional Review Board of the Tran Hung Dao Hospital,
Hanoi, Vietnam. The participants provided written informed
consent.
Results
Baseline Characteristics of the Vietnamese HBsAg-
positive Patients
Two hundred sixty-six Vietnamese HBsAg-positive patients
were included in this study, of which 48/266 (18%) were female
and 218/266 (82%) were male. None of these patients received
antiviral treatment. The median age of the patients was 48
years (15 to 79 years). Median serum HBV load of the patients
was 3.92 log10 HBV-copies/ml (2.46 to 6.37 log10 HBV-copies/
ml). The baseline characteristics of the patients in the different
groups are summarized in Table 2. Patients were not co-
infected with HCV and/or HIV. Patients in the AHB group were
younger (median age 35 years) than those in LC (median age
51 years, p<0.001), HCC (median age 53 years, p<0.001), and
CHB (median age 40 years, p<0.05) group (Table 2). As
expected, the serum alanine aminotransferase (ALT), aspartate
aminotransferase (AST) levels, total bilirubin, and direct
bilirubin concentrations were higher in the AHB group
compared to the other groups (p<0.001) (Table 2). Notably,
there were no significant difference in HBV loads among the
investigated patient groups (AHB, CHB, LC, and HCC)
(ANOVA-test, p=0.70). HBV-genotyping revealed that thirty
HDV-positive patients showed the HBV-genotypes A (6/30;
20%), C (5/30; 16.7%), and D (8/30, 26.6%) as predominant
genotypes. Other HBV-genotypes B, E, and G were only minor
(1/30; 3.3%) and HBV-genotype H was not detectable in the
Vietnamese patient cohort. Notably, 26.6% (8/30) of the HDV-
positive patients showed mixed HBV-genotype infections. 2/30
were HBV-genotype mix A/C (6.6%) and A/D, A/F, B/C, C/D,
C/F, and C/G HBV-genotype mixes were each 1/30 (3.3%)
(Table 3).
Prevalence and Replication of HDV
In order to determine the prevalence of HDV-infection of the
Vietnamese HBsAg-positive patients, we developed a new
HDV Prevalence in Northern Vietnam
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Figure 1.  Strategy of primer design and RT-PCR schema.  (A) Primer design for HDV-specific nested RT-PCR located in a
highly conserved region of the HDV genome. HDV-specific primers HDV-04 and HDV-05 for the first PCR round, HDV-06 and
HDV-07 for the nested PCR were designed for HDV detection and genotyping. The primers were matched and aligned with 38
reference sequences of the eight HDV genotypes available in the NCBI-GenBank. The primer sequences target to the ribozyme and
HDAg domains of the HDV genome. The numbers 1 to 8 of each reference sequence code for the respective HDV-genotype. R1,
R2 = ribozyme domain; C = C-terminal amino acid extension. HDAg: Hepatitis Delta antigen; position marked at nt 1015 indicates
RNA editing site. (B) Schematic representation of primer binding sites. The primers HDV-06 and HDV-07 of the nested PCR used
for HDV detection and HDV-genotyping span the region from nt 888 to nt 1122. The HDV-fragment from the position nt 316 to nt
691 is generated by the primer pair HDV-19 and HDV-20. Numbering is according to HDV strain NC1001653. (C) Representative
example of 1.5% agarose gelelectrophoresis of amplified HDV products. HDV specific nRT-PCR amplicons of 235 bp are shown.
HDV positive samples could be identified in lanes 3, 5, 13, 14, 22, 30, and 32. Positive control (PC) was a HDV full-length plasmid.
NC = negative control. Marker (M) is 100bp DNA ladder.
doi: 10.1371/journal.pone.0078094.g001
HDV Prevalence in Northern Vietnam
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highly sensitive and specific HDV nested RT-PCR (Figure 1A
and 1B). Alignment of the HDV primers HDV-04 to HDV-07
sequences showed that the chosen sequences are highly
conserved between different HDV-strains and HDV-genotypes
of different geographic areas (Figure 1A). The HDV nRT-PCR
amplifies a region of the ribozyme and HDAg domain which is
localized from nucleotide (nt) 888 to nt 1122 (numbering is
according to NC001653) (Figure 1B). Additionally, a second
semi-nested RT-PCR located from nt 316 to nt 691 was
generated to evaluate the results of the nRT-PCR (Figure 1B).
HDV-RNA genomes were detected in 41 out of 266 HBsAg-
positive patients demonstrating a prevalence of 15.4% HDV-
RNA positive HBsAg carriers of our patient collective (CI95
[11.1-19.8], Figure 1C and 2). Of the 41 HDV-positive patients
10/41 were female (24.4%) and 31/41 were male (75.6%)
(p=ns). A detailed analysis revealed that HDV-RNA was
significantly more prevalent in the AHB patient group with
43.3% (13/30) in contrast to the HDV-prevalence of 11.3%
(7/62) in the CHB, 11.9% (10/84) in the LC, and 12.2% (11/90)
in the HCC group [Odd Ratio (OR) =0.19 (CI95 [0.23-0.66]),
0.20 (CI95 [0.08-0.54]), 0.25 (CI95 [0.22-0.71]), respectively;
two tailed Fisher’s exact test, p<0.01] (Figure 2).
Determination of the HDV loads in the sera of all patients
groups showed that viral loads were mainly at or below
detection limit of the quantitative HDV RT-PCR whereas
detection limit was <300 HDV-copies/ml as described
previously (Table 3) [38]. However, in the AHB group 3/30
samples (10%) showed HDV loads of 609, 428 and 4.108
HDV-copies/ml, respectively, and only one sample in the CHB
group revealed 3.738 HDV-copies/ml (1/62, 1.6%) (Table 3).
Interestingly, the higher HDV loads in the AHB and CHB group
were only found in HBV-genotype mix samples.
To explore the impact of HBV-genotypes of HBV/HDV-
coinfection on HBV replication we compared HBV loads of
HDV-positive samples. The HBV loads were significantly higher
in HBV-genotype C in comparison to HBV-genotype A of HDV-
Table 2. Characteristics of HBsAg-positive Vietnamese
patients segregated according to clinical presentation.
 AHB n=30 CHB n=62 LC n=84 HCC n=90
Age (y) 35* 40 51*** 53***
Sex (male/female) 24/6 52/10 66/18 76/14
ALT (IU/L) 969.0*** 147.5 63.0 60.5
AST (IU/L) 1128.5*** 156.5 67.5 59.5
Total Bilirubin (mg/dl) 123.9*** 31.5 29.4 17.5
Direct Bilirubin (mg/dl) 92.7*** 17.0 16.0 8.2
AFP (mg/dl) ND ND ND 87.1
HBV load1 (copies/ml) 3.77 4.05 3.98 3.86
Values given are median; IU, international units; ND: Not Done
*. p<0.05 comparing patient age in the AHB group with the CHB group
***. p<0.001 comparing AHB with other groups
1. Values are given as log10 copies/ml, p=0.70 (Anova test)
AHB: Acute Hepatitis B; CHB: Chronic Hepatitis B; LC: Liver Cirrhosis; HCC:
Hepatocellular carcinoma; ALT: Alanine aminotransferase; ALT: Aspartate
aminotransferase; AFP: Alpha-fetoprotein.
doi: 10.1371/journal.pone.0078094.t002
coinfection samples (4.13 log10 vs 3.63 log10 copies/ml, p<0.05)
(Figure 3A). The lower HBV loads of HBV-genotype A in HDV-
positive samples was confirmed by the close to significantly
higher HBV load of HBV-genotype A monoinfected samples
(4.22 vs 3.63 log10 copies/ml, p=0.053) (Figure 3B).
Table 3. HDV-RNA quantification and HBV-genotype
distribution.
Patient No Diagnosis HDV load (copies/ml) HBV genotypes
C03 AHB <300 ND
C06 AHB <300 a/d
C09 AHB not detected b
C13 AHB <300 ND
C14 AHB <300 ND
C15 AHB <300 c
C16 AHB <300 d
C17 AHB 609 a/c
C18 AHB <300 d
C19 AHB <300 a/c
C21 AHB 428 c/f
C22 AHB 4108 a/f
C31 AHB <300 c/g
A084 CHB not detected c
A092 CHB not detected c
B005 CHB not detected a
B154 CHB not detected d
B172 CHB not detected a
M08 CHB <300 a
M18 CHB 3738 c/d
B122 HCC not detected d
B127 HCC not detected ND
B148 HCC <300 d
B207 HCC not detected ND
U18 HCC ND ND
U25 HCC not detected e
U27 HCC <300 c
U28 HCC not detected a
U33 HCC not detected a
U41 HCC <300 d
U47 HCC <300 ND
A056 LC not detected ND
B094 LC <300 ND
B160 LC not detected d
B162 LC <300 g
B171 LC not detected a
X07 LC not detected c
X08 LC not detected ND
X09 LC not detected d
X11 LC not detected ND
X13 LC not detected b/c
AHB: Acute Hepatitis B; CHB: Chronic Hepatitis B; LC: Liver Cirrhosis; HCC:
Hepatocellular carcinoma; NA: Not done
doi: 10.1371/journal.pone.0078094.t003
HDV Prevalence in Northern Vietnam
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Subclinical Characteristics and Correlation of HDV
Infection to Liver Parameters
The subclinical characteristics of the HDV patients were
described in table 4. In general, the HDV-positive patients were
significantly younger than those of the HDV-negative group
(median age 41 vs 49 years, p<0.05). The aminotransferase
enzymes (ALT and AST: 82.0 and 88.0 IU/l vs. 213.0 and
223.0 IU/l, respectively) as well as total bilirubin (23.9 vs 59.0
mg/dl) and direct bilirubin (13.1 vs 34.3 mg/dl) were
significantly higher in HDV-positive compared to HDV-negative
HBV-infected patients (p<0.001) (Figure 4A and Table 4). The
HBV loads were moderately but not significantly higher in HDV-
negative patients in comparison to HBV/HDV-coinfected
patients (3.98 vs 3.76 log10 copies/ml, p=0.60) (Figure 4B and
Table 4).
Next, we explored the characteristics of the liver parameters
between the different patient groups. Consistently with the
analysis of subclinical characteristics of all analysed patients,
the chronic group (CHB, LC, and HCC) showed significantly
elevated values of ALT (113.0 vs 69.5 IU/l), AST (136.5 vs 75.0
IU/l), total bilirubin (44.7 vs 22.3 mg/dl), and direct bilirubin
(21.3 vs 12.0 mg/dl) in the HDV-positive samples in
comparison to HDV-negative samples (p<0.05) (Figure 4C and
Table 5). In contrast, the assessment of the subclinical profiles
of the HDV-positive patients among the individual chronic
groups (CHB, LC, and HCC) revealed no statistically significant
differences (p>0.05) (Figure 4E to G). However, the fold-
increase values of the liver parameters of these groups varies
for ALT (1.6 to 2.2-fold), AST (1.3 to 1.8-fold), total bilirubin (1.4
to 3.2), and direct bilirubin (1.5 to 4.5-fold) between HDV-
positive and HDV-negative samples (p>0.05) (Table 5).
Additionally, in the AHB group a significant increase of the
already highly elevated liver parameters (ALT, AST, total and
direct bilirubin) could not be determined (p>0.05) (Figure 4D
and Table 5). However, ALT in the LC group showed
Figure 2.  Prevalence of HDV genomes in the HBsAg-
positive Vietnamese patients.  The prevalence of HDV
infection in AHB group was significantly higher in comparison
to the CHB, LC and HCC groups (OR =0.19 (CI95 [0.23-0.66]),
0.20 (CI95 [0.08-0.54]), 0.25 (CI95 [0.22-0.71]), respectively;
two tailed Fisher’s exact test, p<0.01). Overall, the HDV-
prevalence of all patient groups was 15.4% (CI95 [11.1-19.8])
(Total).
doi: 10.1371/journal.pone.0078094.g002
significantly higher ALT values in HDV-positive patients than in
HDV-negative patients (103.5 vs 61.0 UI/l, p<0.05) (Figure 4F
and Table 5). Moreover, AST value was significantly higher in
the CHB group in comparison to the HCC group (193 vs 74
UI/l, p<0.05) (Figure 4E, 4G and Table 5).
HDV Genotype Distribution in the Vietnamese Patients
In order to determine circulating HDV-genotypes in Northern
Vietnam, we could analyse 21 HDV isolates from our patient
collective using direct sequencing in the region from nt 888 to
nt 1122. Patient-specific HDV-isolates could be confirmed by
sequence variations as shown in the analysed HDV-regions
(Figure 5A). All sequences were aligned and phylogenetic
analysis was performed with prototype HDV sequences
obtained from the NCBI-Genbank (Figure 5B). The
Figure 3.  HBV replication of different HBV-genotypes in
HBV/HDV coinfection.  (A) Determination of HBV loads of the
predominant HBV-genotype A and HBV-genotype C samples in
the Vietnamese HDV-positive patients (*denotes p<0.05). (B)
Comparison of HBV loads in the HBV-genotype A samples
according to the status of HDV-coinfection. The HBV load was
closely significantly lower in HDV-positive patients than HDV-
negative patients (p = 0.053). p<0.05 is statistically significant.
doi: 10.1371/journal.pone.0078094.g003
HDV Prevalence in Northern Vietnam
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phylogenetic analysis showed that two HDV-genotypes were
found in our Vietnamese patient cohort, while HDV-genotype 1
was the predominate HDV-genotype (90.5%, 19/21). HDV-
genotype 2 was detectable in two patients (9.5%, 2/21). The
analysed region from nt 888 to nt 1122 of the Vietnamese HDV
strains was highly homologous within the same HDV
genotypes (HDV genotype 1) with a mean sequence identity
from 91.3% to 100%. The homology among different HDV
genotypes (HDV genotypes 1 and 2) was calculated to be 75%
to 79.3%.
Discussion
Hepatitis B virus infection is one of the most serious public
health problems in Vietnam with 10-20% infected individuals of
the general population [29,30]. Although the national universal
HBV vaccine program was introduced in 2003 in Vietnam,
HBV-infected individuals have still steadily increased also
because of the increasing population [31]. The HBV prevalence
will possibly reduce in this area in near future, however, the
incidence and prevalence of HBV-associated LC and HCC
could be gradually increasing in the next two decades due to
the long latency of chronic hepatitis B [31]. There are a number
of factors that shape the clinical course of HBV-infection. One
of these factors is coinfection with other viruses, like HCV, HIV,
B19V and HDV. The HDV infection and its propagation needs
the presence of HBsAg in obligatory [4]. The estimation of the
prevalence of HDV infection is highly variable in different
regions of the world. Recent reports indicated that HDV
infection may have a revival in Europe with a HDV frequency of
8.1%, 11%, 8.5%, and 20.4% in Italy, Germany, England, and
Romania, respectively [40-43]. A high prevalence of HDV
infection has been also described in several Asian countries,
like Pakistan (35.2%) [44], Mongolia (13.6%) [45], and several
provinces in China [46]. In contrast, other reports described a
low incidence of HDV in Asian countries, like South Korea
Table 4. Subclinical characteristics of HBsAg-positive
Vietnamese patients with or without HDV coinfection.
 
Age
















41* 213.0*** 223.0*** 59.0*** 34.3*** 3.76
Values given are median; IU, international units;
*. p<0.05 comparing patient age in the HDV-positive group with the HDV-negative
group
***. p<0.001 comparing liver parameters in the HDV-positive group with the HDV-
negative group
1. Values are given as log10 copies/ml, p=0.60
ALT: Alanine aminotransferase; ALT: Aspartate aminotransferase
doi: 10.1371/journal.pone.0078094.t004
(0.32%) [47], Malaysia (4.9%) [48], and Indonesia (<0.5%) [49].
An explanation for these discrepancies could be the variable
sensitivity of serological and molecular methods (qPCR) used
to determine HDV-infection [50]. Vietnam reflects this
controversial discussion of the HDV prevalence in Asia. Two
previous studies have shown a very low prevalence of HDV
infection in Vietnamese HBsAg-positive carriers of 0% and
1.3% [32,33]. In contrast, a recent report described a
prevalence of HDV of 10.7% in the Vietnamese population
while 25.6% HDV-positive individuals were observed in
Vietnamese injecting drug users and to 17.8% in Vietnamese
military recruits [29].
In order to determine the prevalence of HDV in Vietnam we
developed two highly sensitive HDV-specific nested RT-PCR
methods (Figure 1). As a study population we included 266
HBV-infected patients with well-characterized clinical profiles
[36,37]. Our study population allowed us not only to investigate
the prevalence of HDV in Northern Vietnam but also to shed
light on the influence of HDV on the clinical outcome in
HBV/HDV coinfected patients. Molecular analysis
demonstrated that the frequency of HDV in the HBsAg-positive
patients of Northern Vietnam is 15.4% (CI95 [11.1-19.8], Figure
2). This result is well in accordance with a previous study by
Dunford et al [29] showing 10.7% (CI95 [7.3-14.1]) HDV-
infection in Vietnamese population. However, one possible bias
in our study procedure is the analysis of HBsAg-positive
individuals hospitalized due to clear symptoms of hepatitis B.
Next, we were interested of the significance of HDV infection
on the clinical outcome in HBV/HDV coinfected Vietnamese
patients. Most frequently HDV infection was found in AHB
patients with 43.3%, following 12.2%, 11.9% and 11.3% in the
HCC, LC and CHB patient groups, respectively (Figure 2).
Although different methods and patient collectives were used to
determine the HDV prevalence in acute hepatitis B, the
relatively high HDV frequency in AHB patients is in agreement
with previous studies from Russia and the Peruvian Amazon
Basin showing a HDV-positivity in acute hepatitis of 39% and
64%, respectively [51,52].
The subclinical characteristics of the Vietnamese HBsAg-
positive patients confirmed previous reports showing
acceleration of severe HBV/HDV-associated liver disease by
approx. 2-fold increase in serum aminotransferases (ALT and
AST) and total and direct bilirubin in HDV-RNA positive
compared to HDV-RNA negative patients (p<0.001) (Figure 4)
[53]. In accordance with entire findings, further detailed
analysis in the chronic patient group (CHB, LC, and HCC
group) revealed significantly elevated liver parameters (ALT,
AST, total and direct bilirubin) of the HDV-positive patients in
comparison to HDV-negative patients (p<0.05) (Figure 4).
However, the AHB patient group revealed no significant
differences of the already highly elevated liver parameters
between HDV-positive and HDV-negative patients (p=ns)
(Figure 4).
More unexpected, in opposite to that has been described in
an HBsAg-positive chronic hepatitis Italian cohort in which HBV
viral load is lower in HDV co-infected compared to HDV-
negative patients (median 641 [range, 70 to 9.4 × 107
copies/ml] versus 1.6 x 107 copies/ml [range, 3.1 × 104 to 6.5 ×
HDV Prevalence in Northern Vietnam
PLOS ONE | www.plosone.org 7 October 2013 | Volume 8 | Issue 10 | e78094
Figure 4.  Subclinical characteristics in HBV/HDV coinfection.  (A) Subclinical characteristics of the HBsAg-positive Vietnamese
patients with (dark bars) and without HDV-coinfection (white bars). The serum transferase levels as well as concentration of total
and direct bilirubin were significantly higher in HDV-positive patients than HDV-negative individuals (***denotes p<0.001). (B)
Determination of HBV loads in the different study groups (AHB, CHB, LC, and HCC) and of all patients (total) revealed no
statistically significant differences (p>0.05). (C to G) Subclinical characteristics of HDV-infection of the Vietnamese HBsAg-positive
patients of (C) AHB, (D) total chronic cases (CHB+LC+HCC), (E) CHB, (F) LC, and (G) HCC groups. ALT was significantly higher in
HDV-positive than in HDV-negative patients in LC group (F, * denotes p<0.05). AST was slightly higher in the CHB group in
comparison to the HCC group (E,G, p<0.05). The values at the X-axis are given in log2 scale; ALT and AST = IU/l, bilirubin = mg/dl,
and HBV loads = HBV-copies/ml. p<0.05 is statistically significant. White bars depict HDV-negative and dark bars HDV-positive
samples of the Vietnamese HBsAg-positive patients.
doi: 10.1371/journal.pone.0078094.g004
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108 copies/ml]) [54], respectively, we observed that HBV loads
did not significantly differ between HDV-positive and HDV-
negative patients (Figure 4). This finding may reflect a report
about another chronic hepatitis HBV/HDV-coinfected cohort
showing that the two viruses appeared concomitantly
replicating in 23% of the patients, HBV was suppressed in
70%, and within a few (4%) HDV seems to be inhibited [2].
Analysis of HDV loads revealed that in general in the patient
collective, a low HDV replication activity was detectable (<300
HDV-copies/ml). A HDV load in a range of 2 to 8 log10
copies/ml was often described in HBV/HDV-coinfected patients
[2,38] probably with a nearly extinct HBV replication. Thus, the
low HDV loads detected in our study may be best explained by
the competitive effect (viral interference) of the HBV replication
activities we observed identical in HDV-negative and HDV-
positive patient groups.
Table 5. Liver parameters of HBsAg-positive patients with
or without HDV infection.






AHB HDV-RNA (-) 923.0 968.0 118.0 86.3
 HDV-RNA (+) 1015.0 1422.0 156.0 123.5
CHB HDV-RNA (-) 145.0 148.0 30.0 16.0
 HDV-RNA (+) 318.0 193.0 96.0 72.5
LC HDV-RNA (-) 61.0* 67.5 28.2 14.5
 HDV-RNA (+) 103.5 100.5 51.0 21.3
HCC HDV-RNA (-) 57.0 57.0 17.0 8.2
 HDV-RNA (+) 102.0 74.0 25.0 12.3
CHB + LC
+ HCC
HDV-RNA (-) 69.5* 75.0 22.3* 12.0*
 HDV-RNA (+) 113.0 136.5 44.7 21.3
Values given are median; IU, international units; * denotes p<0.05
AHB: Acute Hepatitis B; CHB: Chronic Hepatitis B; LC: Liver Cirrhosis; HCC:
Hepatocellular carcinoma; ALT: Alanine aminotransferase; ALT: Aspartate
aminotransferase
doi: 10.1371/journal.pone.0078094.t005
Nearly exclusively in the AHB group, HDV-loads of 609 to
4.108 HDV-copies/ml could be detected demonstrating active
HDV-replication. Interestingly, the higher HDV-loads were
secondary only detectable in HBV-genotype mix infections.
Interviral interference between HBV-genotypes in genotype mix
infections can lead to suppression of one of the participating
HBV-genotypes [55]. Therefore, HDV could possibly have an
advantage as the “third man lucky”. Additionally, HBV-loads
were significantly higher in HBV-genotype C in comparison to
HBV-genotype A of HDV-positive patients (Figure 3) (p<0.05).
Determination of circulating HDV genotypes in Vietnam has
not been performed to date. The phylogenetic analysis of the
present study showed that the predominant HDV-genotype was
HDV-genotype 1 (90.5%) which mainly clustered to the Asian
HDV-genotype 1 branch. One HDV strain (B171) was closely
related with the HDV-genotype 1 strain of Central Africa
(AJ000558) showing a 91% bootstrap value (Figure 5).
Our results suggest a wider distribution of HDV genotype 1
and did not support a narrow geographical spread of distinct
HDV subtypes. Furthermore, HDV-genotype 2 was also
detected in our patient cohort which was commonly found in
Taiwan [11], Japan [12] and Russia [13].
In conclusion, the results of the present study showed a high
prevalence of HDV (15.4%) and were most prevalent in the
acute hepatitis group (43.3%) while HDV-genotype 1 is the
predominant virus in the Vietnamese HBsAg-positive patients.
HBV/HDV coinfection could be associated with constantly
elevated liver parameters, a finding which is mainly found in the
chronically infected patient groups (CHB, LC, and HCC) and
not in acute infections, if compared HDV-positive patients with
HDV-negative patients. HDV replication activity seemed to
favor HBV genotype mixes and distinct HBV genotypes (HBV-
A) revealing that HDV may have a HBV-genotype dependency.
However, the cross-sectional study design with the bias of
hospitalized HBsAg-positive patients prevents us from drawing
more definitive conclusions which should be evaluated in
further studies. We conclude that molecular tests should be
used in routine diagnostics to detect HDV in HBsAg-positive
patients even when elevated liver parameters are presented.
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Figure 5.  HDV-genotype distribution in Vietnamese HBsAg-positive patients.  (A) Representative HDV sequences of the
HBsAg-positive patients aligned with HDV reference sequence NC001653. HDV sequences spanning the region from nt 335 to nt
635 showing patient-specific HDV isolates. (B) Phylogenetic analysis inferred from distance analysis (Kimura 2 parameters model)
and neighbor-joining reconstruction from HDV-sequences (nt 888 to nt 1122) of the Vietnamese HDV isolates and the
corresponding region of the reference sequences showing that the Vietnamese HDV isolates clustered mainly in the Asian HDV-
genotype 1 branch and two isolates (C03 and C06) in the HDV-genotype 2 branch. Vietnamese HDV sequences are referred to as
“letter/number”, i.e., “B127”. The Vietnamese HDV sequences were compared to HDV reference sequences, gathering the 8 HDV
genotypes which are denoted at the right in brackets (NCBI-Genbank accession numbers are denoted in the figure). The numbers
at the nodes indicate bootstrapping values. The bar represents nucleotide substitutions per position.
doi: 10.1371/journal.pone.0078094.g005
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